Polyrizon Ltd. PLRZ
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Operating income | -$6.2M | -$1.3M | -$635,000 |
| Net income | -$3.3M | -$1.5M | -$600,000 |
| Operating cash flow | -$4.5M | -$1.1M | -$537,000 |
| Free cash flow | -$4.5M | — | — |
| Total assets | $21.4M | $5.5M | $559,000 |
| Shareholders' equity | $21.0M | $5.3M | -$191,000 |
| Ratios | |||
| Return on assets | -15.6% | -27.9% | -107.3% |
| Return on equity | -15.9% | -29.2% | 314.1% |
| Current ratio | 29.03 | 10.16 | 0.11 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001893645 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.